RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human leukocyte antigen (HLA) gene-editing abstract has ...
Five9, Inc. (Nasdaq: FIVN), provider of the Intelligent CX Platform, today announced the appointment of Sudhakar Ramakrishna to its Board of Directors (the "Board") effective September 26, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback